Evaluation of Oxidative Stress and Methylated Arginine Levels in Individuals With Periodontitis
NCT06973148 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2025-05-15
Summary
You are being invited to participate in a scientific research study. Before you decide to take part, it is essential that you understand why the study is being conducted and what your participation will involve. Please take the time to read the following information carefully. Feel free to ask if anything is unclear or need more details.
This study aims to evaluate saliva composition, specifically focusing on amino acid and protein building blocks, oxidative stress, and the Nitric Oxide metabolism system, including levels of ADMA (Asymmetric Dimethylarginine) and SDMA (Symmetric Dimethylarginine). By examining these parameters, we aim to contribute to a better understanding of the biological mechanisms involved in gum health and systemic responses.
You have been selected to participate in this study based on your periodontal (gum) health status. A total of 40 individuals, 20 diagnosed with periodontitis and 20 diagnosed as periodontally healthy, who meet the study criteria, will be included.
If you choose to participate, you will receive non-surgical periodontal treatment as part of your routine care. Before the treatment, biological samples, including saliva and serum, will be collected. These samples will be used solely for scientific analysis and will not affect the outcome of your dental treatment. Although the total duration of the study is 2 years, your involvement will conclude at the beginning of periodontal therapy.
There are no anticipated risks associated with participation beyond those commonly encountered during dental examinations and treatments. You will not benefit directly; however, your contribution will help advance scientific knowledge about the factors influencing oral and systemic health.
All information collected from you during the study will remain confidential. Your identity will be protected, and personal data will not be disclosed in any reports or publications resulting from this study.
Participation in this study is entirely voluntary. You are free to decline or withdraw at any time, without needing to give a reason. Your decision will not affect the quality of care you receive.
All tests, examinations, and procedures performed as part of this study will be provided at no cost to you. Participation will not result in any financial cost or compensation.
Conditions
- Periodontitis
- Oxidative Stress
Sponsors & Collaborators
-
Ankara University
collaborator OTHER -
Medipol University
collaborator OTHER -
Ankara Medipol University
lead OTHER
Principal Investigators
-
Zeliha Guney · Ankara Medipol University
-
Sivge Kurgan, Prof. · Ankara University
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-06-07
- Primary Completion
- 2022-12-19
- Completion
- 2022-12-19
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
The Importance of Prostaglandin and Nitric Oxide Synthesis in Apical Periodontitis
NCT06023901 ·Status: COMPLETED ·Phase: NA
-
Assessment of Salivary Biomarker Levels in Individuals With Various Periodontal Diseases
NCT07025291 ·Status: COMPLETED ·Phase: NA
-
Effect of Non-surgical Periodontal Treatment on Oxidative Stress and Antioxidant Status in OSAS
NCT03268473 ·Status: COMPLETED ·Phase: NA
-
Tissue Alterations in Aggressive and Chronic Periodontitis
NCT03625414 ·Status: COMPLETED
-
Comparison of Saliva Biomarkers in Two Different Geographical Regions of Turkey
NCT06809439 ·Status: COMPLETED ·Phase: NA
-
Advanced Oxidation Protein Product and Monocyte Chemoattractant Protein-1 in Periodontal Disease
NCT02848378 ·Status: COMPLETED
-
Non-surgical Periodontal Treatment and Periostin Levels
NCT05535049 ·Status: COMPLETED ·Phase: NA
-
EVALUATION OF SALIVA AND SERUM HEME OXYGENASE, ARYLESTERASE AND NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2 LEVELS IN PATIENTS WITH STAGE III PERIODONTITIS
NCT06986044 ·Status: COMPLETED
-
Evaluation of the Potential Effects of LRP5 and Tph1 in the Pathogenesis of Periodontal Disease Individuals With Stage III Grade B Periodontitis
NCT06933797 ·Status: COMPLETED
-
IL-6, IL-17 and IL-35 Levels in the Gingival Crevicular Fluid of Patients With Periodontitis and Healthy Controls
NCT05306860 ·Status: COMPLETED
-
Periodontal Disease and Salivary Mitofusin Levels
NCT06510608 ·Status: NOT_YET_RECRUITING
-
Salivary Proteome in Response to Non-surgical Periodontal Treatment
NCT05952895 ·Status: COMPLETED
-
An Evaluation of Salivary Oxidant and Antioxidant Levels in Peri-implant Health and Disease
NCT05724706 ·Status: COMPLETED
-
Bactericidal Permeability Protein Inhibitor and Interleukin-1beta Levels After Non-surgical Periodontal Treatment
NCT06354504 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effect of Non-Surgical Periodontal Treatment in Women With Polycystic Ovary Syndrome
NCT06567132 ·Status: COMPLETED ·Phase: NA
-
Salivary Mitofusin-1 Levels in Periodontitis: Associations With Disease Severity, Smoking, and Treatment Response
NCT07262606 ·Status: RECRUITING ·Phase: NA
-
Impact of Non Surgical Periodontal Therapy on Cystatin C Levels
NCT07103421 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Biomarker Levels in Gingival Crevicular Fluid of Patients With Different Periodontal Diseases
NCT04777487 ·Status: COMPLETED ·Phase: NA
-
Assessment of Salivary GM-CSF, MIP, and IL-1β Levels in Subjects With Varying Periodontal Conditions
NCT06961409 ·Status: RECRUITING
-
Periodontal Health and Quality of Life in Psoriasis Patients
NCT07154420 ·Status: COMPLETED
-
Evaluation of SOST, TWEAK, RANKL, OPG Levels in Smokers and Non-Smokers With Periodontitis
NCT06103578 ·Status: COMPLETED
-
Chronic Periodontitis and Polycystic Ovary Syndrome
NCT02954120 ·Status: COMPLETED
-
Hepcidin Levels in Periodontal Health and Disease
NCT03789565 ·Status: COMPLETED
-
Effect of Non-Surgical Periodontal Treatment on Biomarker Levels
NCT06178081 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Biomarkers Levels in Gingival Crevicular Fluid, Saliva and Serum for Different Periodontal Diseases
NCT05435131 ·Status: COMPLETED ·Phase: NA